Cincinnati has won an off-court battle in the Crosstown Shootout.  Former Xavier basketball trainer Connor Barnes is joining ...

Git isn't hard to learn, and when you combine Git and GitHub, you've just made the learning process significantly easier. This two-hour Git and GitHub video tutorial shows you how to get started with ...

O'Connell projected, "We expect to read out ALTITUDE-AD late this year, inclusive of key clinical efficacy and safety measures." He indicated that results from this study would inform development ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Voters thought President Donald Trump’s supposed business acumen would improve the economic wellbeing of rich and poor alike. But his impact shows otherwise. These are just a few examples of poor ...

Acumen Pharmaceuticals (NASDAQ:ABOS) is set to give its latest quarterly earnings report on Wednesday, 2025-11-12. Here's what investors need to know before the announcement. Analysts estimate that ...

One former Pfizer building is undergoing a monumental residential conversion courtesy of Nathan Berman and David Werner, the largest office-to-resi conversion in New York City. Another is celebrating ...

When I was president of Amber Brookman Fabrics, my parent company faced severe financial distress caused by dishonest leadership and fraudulent practices. When no one else was willing or able to lead, ...

Days after JCR Pharmaceuticals signed a deal with AstraZeneca’s rare disease unit, the Japanese biopharma has secured a $555 million biobucks pact with Alzheimer’s-focused Acumen Pharmaceuticals. The ...

Fintel reports that on June 17, 2025, Citigroup initiated coverage of Acumen Pharmaceuticals (NasdaqGS:ABOS) with a Buy recommendation. Analyst Price Forecast Suggests 682.89% Upside As of June 2, ...